Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
J Hippisley-Cox, M Patone, XW Mei, D Saatci, S Dixon… - bmj, 2021 - bmj.com
Objective To assess the association between covid-19 vaccines and risk of
thrombocytopenia and thromboembolic events in England among adults. Design Self …
thrombocytopenia and thromboembolic events in England among adults. Design Self …
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
SE Daugherty, Y Guo, K Heath, MC Dasmariñas… - Bmj, 2021 - bmj.com
Objective To evaluate the excess risk and relative hazards for developing incident clinical
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …
Severe covid-19 pneumonia: pathogenesis and clinical management
AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
Severe covid-19 pneumonia has posed critical challenges for the research and medical
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …
2 infection and is associated with both acute and chronic disorders affecting the nervous …
Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …
E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …